Diet plan may help fight muscle weakness in liver cirrhosis
NCT ID NCT07625085
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
Liver cirrhosis often causes muscle weakness and frailty, even in stable patients. This study tested whether a personalized diet with extra calories and protein, along with nutrition counseling, could improve muscle strength and quality of life. About 70 adults with stable cirrhosis were randomly assigned to either the diet plan or usual care, and followed for 16 weeks.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- individualized diet plan (calorie and protein targets from regular foods, plus nutrition counseling)
- What this could lead to
- If it works, this could show that simple dietary changes can help people with liver cirrhosis maintain muscle strength and reduce frailty, improving daily life.
- What could go wrong
- This is a small, completed study with only 70 participants, so results may not apply to everyone. Diet plans can be hard to follow, and the effect on muscle strength may be modest.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
70 people
The number who actually took part.
- Started
-
Mar 2023
- Finished
-
Oct 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: ● Confirmed diagnosis of liver cirrhosis based on clinical, biochemical, radiological, and/or histological evidence. * Outpatients who were clinically stable at the time of enrolment. * Child-Turcotte-Pugh (CTP) score ≤ 10. Exclusion Criteria: * Already receiving a structured nutrition intervention program or high-protein supplementation. * Presence of other severe co-morbidities that could confound outcomes. * History of chronic or recurrent hepatic encephalopathy. * Active alcohol consumption at the time of screening. * Expected poor compliance with study procedures. * Refusal to provide consent for participation. * Pregnant or lactating women.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Liver cirrhosis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Policlinico Umberto I
Rome, Lazio, 00185, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria in a capsule: a new attempt to calm a brain complication of cirrhosis
- Can a digital platform catch liver cancer sooner?
- Can a Two-Drug combo keep cirrhosis patients out of the hospital?
- Can removing the spleen help the liver fight cancer?
- Blood test may forecast which cirrhosis patients survive after discharge
- Can a parasite drug help fight a deadly gut infection in cirrhosis?